Benlysta (belimumab)

Belimumab (trade name Benlysta, previously known as LymphoStat-B) is a human monoclonal antibody that inhibits B-cell activating factor (BAFF), also known as B-lymphocyte stimulator (BLyS).[2] B cells are responsible for part of the normal immune response, and also for the over-aggressive immune response in autoimmune diseases like systemic lupus erythematosus (SLE)... Wikipedia

 

 

 

Manufacturer's Website: Benlysta                                                                                                                 Average retail cost: $509/vial

Search Terms: Benlysta, belimumab, lupus, autoimmune diseases, systemic lupus erythematosus, SLE